Impulse Dynamics® Presented Real-World, Late-Breaking Data Revealing Heart Failure Hospitalization Reduction and Sustained Clinical Benefits of CCM® Therapy at One Year
U.S.
Post-Approval Study Results Presented at Heart Failure Society of America Annual Meeting MARLTON, N.J., Oct.
12, 2026 (GLOBE NEWSWIRE) — Impulse Dynamics®, a global medical device company dedicated to improving the
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.
